---
title: "OGN: Revenue and net income fell as biosimilar growth offset declines in core brands; Sun Pharma deal advances"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294516404.md"
description: "Revenue and net income declined year-over-year, with strong biosimilar growth offset by declines in key women's health and established brands. The company completed a major divestiture, advanced biosimilar collaborations, and received stockholder approval for acquisition by Sun Pharma, with closing expected in early 2027.Original document: Organon & Co. [OGN] SEC 10-Q Quarterly Report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-31T12:51:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294516404.md)
  - [en](https://longbridge.com/en/news/294516404.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294516404.md)
generator: "portal-rs"
---

# OGN: Revenue and net income fell as biosimilar growth offset declines in core brands; Sun Pharma deal advances

Revenue and net income declined year-over-year, with strong biosimilar growth offset by declines in key women's health and established brands. The company completed a major divestiture, advanced biosimilar collaborations, and received stockholder approval for acquisition by Sun Pharma, with closing expected in early 2027.

Original document: Organon & Co. \[OGN\] SEC 10-Q Quarterly Report — Aug. 4 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OGN.US](https://longbridge.com/en/quote/OGN.US.md)

## Related News & Research

- [Quest Diagnostics teams with Humanity to offer biological age analysis on Questhealth.com](https://longbridge.com/en/news/296926398.md)
- [SalMar – Record-strong biological performance](https://longbridge.com/en/news/296859687.md)
- [Roche unit Flatiron expands NSCLC Panoramic dataset with specimen-level biomarker model across 345,000+ patients](https://longbridge.com/en/news/296919271.md)
- [Lexaria says DehydraTECH 3.0 retatrutide tablet boosts absorption up to 4,552% in dog study](https://longbridge.com/en/news/296793626.md)
- [374Water completes Phase 3 of St. Cloud mobile AirSCWO deployment for PFAS-laden biosolids](https://longbridge.com/en/news/296910774.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**